Medicare Enrolled
Dr. Nevine Carp, M.D.
Critical Care Medicine · Boynton Beach, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Carp from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carp?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Carp
Dr. Nevine Carp is a critical care medicine specialist in Boynton Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Carp performed 4,096 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Carp received a total of $9,744 from 37 pharmaceutical and/or device companies across 459 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Carp is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 6% volume in FL
$9,744 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,096
Medicare services
Top 6% in FL for critical care medicine
Not available
Unique patients (not deduplicated)
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
947 | $64 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
910 | $70 | $165 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
383 | $21 | $65 |
| Inhalation treatment for acute airway obstruction, first hour This procedure involves administering inhaled medication to treat acute airway obstruction during the first hour of treatment. |
348 | $46 | $85 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
315 | $35 | $135 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
310 | $45 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
234 | $128 | $325 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
231 | $104 | $275 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
146 | $100 | $185 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
70 | $25 | $155 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
59 | $98 | $170 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
48 | $87 | $525 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
24 | $111 | $225 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
18 | $218 | $317 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $136 | $289 |
| New patient office visit, complex (60-74 min) | 13 | $165 | $350 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $75 | $135 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
12 | $168 | $298 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,744
Total received (2018-2024)
Avg $1,392/year across 7 years
Top 18% in FL for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
459
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,829
2023
$2,278
2022
$1,782
2021
$861
2020
$722
2019
$1,624
2018
$647
Payments by company (2024)
Boehringer Ingelheim Pharmaceuticals, Inc.
$364
AstraZeneca Pharmaceuticals LP
$264
Actelion Pharmaceuticals US, Inc.
$225
GlaxoSmithKline, LLC.
$197
Insmed, Inc.
$114
Amgen Inc.
$113
SANOFI-AVENTIS U.S. LLC
$100
Regeneron Healthcare Solutions, Inc.
$85
GENZYME CORPORATION
$75
United Therapeutics Corporation
$47
Merck Sharp & Dohme LLC
$46
Janssen Pharmaceuticals, Inc
$37
INOGEN, INC.
$36
Mylan Specialty L.P.
$33
Philips North America LLC
$27
ANI Pharmaceuticals, Inc.
$27
Alnylam Pharmaceuticals Inc.
$24
Paratek Pharmaceuticals, Inc.
$14
Top 3 companies account for 46.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,976
AstraZeneca Pharmaceuticals LP
$1,745
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,727
Actelion Pharmaceuticals US, Inc.
$917
Mylan Specialty L.P.
$511
Inogen, Inc.
$377
Philips Electronics North America Corporation
$281
Amgen Inc.
$247
Regeneron Healthcare Solutions, Inc.
$239
United Therapeutics Corporation
$227
Insmed, Inc.
$173
Biosense Webster, Inc.
$140
E.R. Squibb & Sons, L.L.C.
$126
Janssen Pharmaceuticals, Inc
$121
SANOFI-AVENTIS U.S. LLC
$100
GENZYME CORPORATION
$97
Genentech USA, Inc.
$78
Sunovion Pharmaceuticals Inc.
$67
Fisher & Paykel Healthcare Inc
$53
Takeda Pharmaceuticals U.S.A., Inc.
$50
Merck Sharp & Dohme LLC
$46
Grifols USA, LLC
$46
Bayer HealthCare Pharmaceuticals Inc.
$40
Paratek Pharmaceuticals, Inc.
$37
INOGEN, INC.
$36
Covis Pharma GmBH
$33
Electromed, Inc.
$32
Pulmonx Corporation
$30
Philips North America LLC
$27
Circassia Pharmaceuticals Inc
$27
ANI Pharmaceuticals, Inc.
$27
Alnylam Pharmaceuticals Inc.
$24
Vapotherm Inc
$20
CSL Behring
$19
Shire North American Group Inc
$17
Resmed Corp
$16
PFIZER INC.
$14
Top 3 companies account for 55.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirMini · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · CARTO 3 · CHARTIS CATHETER · DIFICID · DUPIXENT · ELIQUIS · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · GIVLAARI · GLASSIA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · Kcentra · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPDIVO · OPSUMIT · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · Utibron · XARELTO · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Critical care medicines in nearby ZIP areas
30
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
BETHESDA HOSPITAL EAST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Carp is a clinical cardiology specialist, with above-average Medicare volume (top 6% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Carp experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Carp performed 947 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Carp receive payments from pharmaceutical companies?
Yes. Dr. Carp received a total of $9,744 from 37 companies across 459 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carp's costs compare to other critical care medicines in Boynton Beach?
Dr. Carp's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carp) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Boynton Beach
Browse critical care medicines in Boynton Beach ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in FL
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in FL
Which FL critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology